1-8 of 8
Uwe Reusch, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preclinical Characterization of AFM26, a Novel B Cell Maturation Antigen (BCMA)-Directed Tetravalent Bispecific Antibody for High Affinity Retargeting of NK Cells Against Myeloma

Thorsten Ross, PhD, Uwe Reusch, PhD, Susanne Wingert, PhD, Torsten Haneke, PhD, Katja Klausz, PhD, Anna-Kathrin Otte, PhD, Natalie Schub, MD, Stefan Knackmuss, PhD, Thomas Müller, Kristina Ellwanger, PhD, Ivica Fucek, Ute Schniegler-Mattox, Joachim Koch, PhD, Thomas Valerius, MD, Martin Gramatzki, MD, Matthias Peipp, PhD, Michael Tesar, PhD, Erich Rajkovic, PhD MBA, Martin Treder, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1927.
https://doi.org/10.1182/blood-2018-99-118970
Published: 2018
Journal Articles

CD16A-Specific Tetravalent Bispecific Immune Cell Engagers Potently Induce Antibody-Dependent Cellular Phagocytosis (ADCP) on Macrophages

Susanne Wingert, PhD, Uwe Reusch, PhD, Armin Beez, Jens Pahl, PhD, Adelheid Cerwenka, PhD, Joachim Koch, PhD, Martin Treder, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1111.
https://doi.org/10.1182/blood-2018-99-118427
Published: 2018
Journal Articles

AFM26 - Targeting B Cell Maturation Antigen (BCMA) for NK Cell-Mediated Immunotherapy of Multiple Myeloma

Thorsten Gantke, PhD, Uwe Reusch, PhD, Christian Kellner, PhD, Katja Klausz, PhD, Torsten Haneke, PhD, Stefan Knackmuss, PhD, Thomas Müller, Kristina Ellwanger, PhD, Ivica Fucek, Ute Schniegler-Mattox, Joachim Koch, PhD, Anne Kerber, MD, Matthias Peipp, PhD, Martin Treder, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3082.
https://doi.org/10.1182/blood.V130.Suppl_1.3082.3082
Published: 2017
Journal Articles

Functional Defects of T Cells of NHL Patients after Different Chemotherapy Regimens Activated By CD19/CD3 Tetravalent Bispecific TandAb ® AFM11

Johannes Duell, MD, Dragana Slavkovic, PhD, Margarete Karg, Uwe Reusch, PhD, Florian Eisele, Jens-Peter Marschner, MD, Hermann Einsele, MD, Martin Treder, PhD, Max S. Topp, MD
Journal: Blood
Blood (2016) 128 (22): 4130.
https://doi.org/10.1182/blood.V128.22.4130.4130
Published: 2016
Journal Articles

Trispecific Antibodies for Selective CD16A-Directed NK-Cell Engagement in Multiple Myeloma

Thorsten Gantke, PhD, Michael Weichel, PhD, Uwe Reusch, PhD, Kristina Ellwanger, PhD, Ivica Fucek, Remko Griep, PhD, Vera Molkenthin, PhD, Oscar Kashala, MD PhD DSc, Martin Treder, PhD
Journal: Blood
Blood (2016) 128 (22): 4513.
https://doi.org/10.1182/blood.V128.22.4513.4513
Published: 2016
Journal Articles

AFM13 Is the Most Advanced Bispecific NK-Cell Engaging Antibody in Clinical Development Substantially Enhancing NK-Cell Effector Function and Proliferation

Jens Pahl, PhD, Uwe Reusch, PhD, Thorsten Gantke, PhD, Anne Kerber, MD, Joachim Koch, PhD, Martin Treder, PhD, Adelheid Cerwenka, PhD
Journal: Blood
Blood (2016) 128 (22): 1764.
https://doi.org/10.1182/blood.V128.22.1764.1764
Published: 2016
Journal Articles

CD30/CD16A Tandab AFM13-Induced Target Cell Lysis By NK-Cells Is Enhanced By CD137 Co-Stimulation and Blocking PD-1

Xing Zhao, Narendiran Rajasekaran, PhD, Uwe Reusch, PhD, Jens-Peter Marschner, MD, Martin Treder, Holbrook Kohrt, MD
Journal: Blood
Blood (2015) 126 (23): 2747.
https://doi.org/10.1182/blood.V126.23.2747.2747
Published: 2015
Journal Articles

In Vitro and In Vivo Characterization of CD19/CD3 Tandab AFM11 and CD19/CD16A Tandab AFM12 Targeting NHL

Xing Zhao, Narendiran Rajasekaran, PhD, Uwe Reusch, PhD, Michael Weichel, Kristina Ellwanger, Jens-Peter Marschner, MD, Martin Treder, Holbrook Kohrt, MD
Journal: Blood
Blood (2015) 126 (23): 2763.
https://doi.org/10.1182/blood.V126.23.2763.2763
Published: 2015